Pharma & Biotech News #PharmaBuzz

Market Place

Sourcing Support

Weekly News Recap #Phispers

Advent to sell generic unit to PE firm GTCR for US$ 4.8 billion; Novo shapes up for obesity race by cutting 9,000 jobs

In this week’s news, Advent International has agreed to sell the Czech generic drugmaker Zentiva to private equity firm G...

Impressions : 467

Novartis inks US$ 5.2 bn cardiology deal with China's Argo, US$ 2 bn deal with Arrowhead; FDA okays first GLP-1 generic for weight

Novartis signed two deals this week — a US$ 5.2 billion cardiology deal with China’s Argo Biopharmaceuticals, and a...

Impressions : 676

White House sacks CDC director; FDA okays Ionis' Dawnzera, first RNA-based preventive for hereditary angioedema

The Trump administration has fired US Centers for Disease Control and Prevention (CDC) Director Susan Monarez, post a policy di...

Impressions : 982

FDA grants accelerated approval to Wegovy for treating MASH; Lilly, Superluminal ink US$1.3 bn AI deal to treat obesity

This week’s Phispers brings you updates on key drug approvals. The US Food and Drug Administration (FDA) has granted acce...

Impressions : 1296

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

Advent to sell generic unit to PE firm GTCR for US$ 4.8 billion; Novo shapes up for obesity race by cutting 9,000 jobs

Novartis inks US$ 5.2 bn cardiology deal with China's Argo, US$ 2 bn deal with Arrowhead; FDA okays first GLP-1 generic for weight

White House sacks CDC director; FDA okays Ionis' Dawnzera, first RNA-based preventive for hereditary angioedema

FDA grants accelerated approval to Wegovy for treating MASH; Lilly, Superluminal ink US$1.3 bn AI deal to treat obesity

Celltrion's Biologics Stoboclo Receives Suppl Approval in US

Celltrion's Biologics Osenvelt Receives Suppl Approval in US

Horizon's Biologics Tepezza Receives Suppl Approval in US

Aurobindo's Generics Deferasirox Receives Approval in US

Epic's Generics Ivermectin Receives Approval in US

Aurobindo's Generics Prochlorperazine Receives Approval in US

Alembic's Generics Phytonadione Receives Approval in US

MSN's Generics Dapagliflozin Receive Tentative Approval in US

Genentech's Biologics Susvimo Receives Supple Approval in US

Torrent's Generics Pazopanib HCl Receives Approval in US

Mera Cannabis Corp.'s Fails EDQM inspection

Ilko Ilac Sanayi Ve Ticaret A.S's Fails EDQM inspection

Enforcement Report - Week of September 10, 2025

Hikal Limited Recieves Warning Letter

FDA Issues Form 483 to GenoGenix

Enforcement Report - Week of September 3, 2025

Wisconsin Pharmacal Recieves Warning Letter

Amneal Pharmaceuticals Recieves Warning Letter

FDA Issues Form 483 to AnazaoHealth Corporation

Green Lumber Alerts Consumers on Counterfeits After FDA Findings

OranoMed Hits Milestone in Facility Build for Lead-212 Therapies

IASO Bio Reveals Equecabtagene Autoleucel for Multiple Sclerosis

First Patient Dosed in Opamtistomig's Melanoma Phase 1b/II Trial

General Meeting Update for September 30, 2025

Telangana DCA Seizes Cefuroxime in Nizamabad Quack's Clinic Raid

Bulk Drugs and Intermediates Exports Rise 10% in July

AMMOI Calls for GST Exemption on Classical Ayurvedic Medicines

CDSCO Removes Voglibose+Metformin Hcl 500mg from April List

Angle PLC Reveals Board Changes

Pharma Exporters Request Reversal of India-Only Drug Export Ban

CDSCO Removes Voglibose+Metformin Hcl 500mg from April List

Amneal Receives U.S. FDA Approval of Sodium Oxybate Oral Solution

AbbVie Shares Hit Record on Immunology Drug Exclusivity Till 2037

NastLaw Announces Settlement in Generic Pharma Pricing Litigation

CVS Sues Takeda Over 'Pay-For-Delay' Scheme

Lupin Gets FDA Nod for Risperidone Long-Acting Injectable

Alembic Receives FDA Final Approval for Phytonadione Injectable

Private equity GTCR strikes $4.8 billion deal to buy Zentiva

A.forall Boosts US Generics Portfolio

Trump Excludes Generics from US-Japan Trade Deal

OranoMed Hits Milestone in Facility Build for Lead-212 Therapies

IASO Bio Reveals Equecabtagene Autoleucel for Multiple Sclerosis

First Patient Dosed in Opamtistomig's Melanoma Phase 1b/II Trial

General Meeting Update for September 30, 2025

Merck touts Capvaxive's potential to provide protection for kids

Sanofi's SAR402663 Granted Fast Track Status for Neovascular AMD

ENHERTU Type II Variation Validated in EU for HER2 Solid Tumors

Ferring Japan NDA for Nadofaragene Firadenovec Accepted by PMDA

VieCure, N-Power Medicine Boost Precision Medicine in Oncology

DNAnexus, Oracle Collaborate for Genomic Insights in Care

Bulk Drug and Intermediate Imports Grow 5% in July

Aparna Pharma Get EUGMP Certification for Pydibhimavaram Facility

Brenntag to Distribute Kerry's Pharma-Grade Acetates in EU

Finetech Launches NJP-1200 for Soft+Hard Capsule Filling

Pharma Firms Applaud Lower Drug Prices, API Tax Gap Concerns Rise

BioNxt Begins Lab-Scale ODF Development with Semaglutide API

Trump's Initiative to Strengthen US API Supply Chain Receives

Allchem Lifescience receives SEBI approval to launch its IPO

Sai Life Sciences Completes Phase II Expansion at Bidar Site

Bayer is charting $43M in upgrades to API plant in Mexico

Telangana DCA Seizes Cefuroxime in Nizamabad Quack's Clinic Raid

Pharma Exporters Request Reversal of India-Only Drug Export Ban

Delhi DC Dept Targets Illegal Sale of MTP Kits Nationwide

FDA Targets Drug Ads, Vows to Close Provision 'Loophole'

FDA Finds Sun Pharma's Halol Plant Non-Compliant with Rules

FDA Warns Indian Drugmaker for Quality Lapses, Enrollment Issues

CDSCO Achieves 97% Digitization for Indian Drug Regulation: DCGI

Philips Under French Criminal Probe for Sleep Apnea Recall

Europe Warns of Surge in Illegal Obesity Drugs

FDA Inspects Biocon Biologics' Bengaluru Facility

Diality Treats First Patient in Moda-flx Home IDE PRESCRIBE Trial

Calyxo Unveils CVAC System and Two-Year ASPIRE Data at WCET 2025

Guardant, LabFlorida Partner to Offer Shield CRC Test to Seniors